The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality disorder (BPD), attention-deficit/hyperactivity disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback